1. Home
  2. SNY vs SOUNW Comparison

SNY vs SOUNW Comparison

Compare SNY & SOUNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • SOUNW
  • Stock Information
  • Founded
  • SNY 1994
  • SOUNW 2005
  • Country
  • SNY France
  • SOUNW United States
  • Employees
  • SNY N/A
  • SOUNW 842
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • SOUNW EDP Services
  • Sector
  • SNY Health Care
  • SOUNW Technology
  • Exchange
  • SNY Nasdaq
  • SOUNW Nasdaq
  • Market Cap
  • SNY 123.6B
  • SOUNW N/A
  • IPO Year
  • SNY N/A
  • SOUNW N/A
  • Fundamental
  • Price
  • SNY $53.72
  • SOUNW $4.20
  • Analyst Decision
  • SNY Buy
  • SOUNW
  • Analyst Count
  • SNY 2
  • SOUNW 0
  • Target Price
  • SNY $62.50
  • SOUNW N/A
  • AVG Volume (30 Days)
  • SNY 3.6M
  • SOUNW 104.1K
  • Earning Date
  • SNY 04-24-2025
  • SOUNW 02-27-2025
  • Dividend Yield
  • SNY 3.05%
  • SOUNW N/A
  • EPS Growth
  • SNY 39.56
  • SOUNW N/A
  • EPS
  • SNY 5.45
  • SOUNW N/A
  • Revenue
  • SNY $48,817,552,946.00
  • SOUNW $67,297,000.00
  • Revenue This Year
  • SNY $5.35
  • SOUNW N/A
  • Revenue Next Year
  • SNY $6.69
  • SOUNW N/A
  • P/E Ratio
  • SNY $9.68
  • SOUNW N/A
  • Revenue Growth
  • SNY N/A
  • SOUNW 76.05
  • 52 Week Low
  • SNY $45.80
  • SOUNW $4.84
  • 52 Week High
  • SNY $60.12
  • SOUNW $6.16
  • Technical
  • Relative Strength Index (RSI)
  • SNY 53.35
  • SOUNW N/A
  • Support Level
  • SNY $52.23
  • SOUNW N/A
  • Resistance Level
  • SNY $53.70
  • SOUNW N/A
  • Average True Range (ATR)
  • SNY 1.23
  • SOUNW 0.00
  • MACD
  • SNY 0.39
  • SOUNW 0.00
  • Stochastic Oscillator
  • SNY 98.61
  • SOUNW 0.00

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

About SOUNW SoundHound AI Inc. Warrant

SoundHound AI Inc is an innovator of conversational intelligence, offering an independent Voice AI platform that enables businesses across industries to deliver high-quality conversational experiences to customers. The company's voice AI delivers speed and accuracy in numerous languages to product creators and service providers across retail, financial services, healthcare, automotive, smart devices, and restaurants via groundbreaking AI-driven products like Smart Answering, Smart Ordering, Dynamic Drive-Thru, and Amelia AI Agents.

Share on Social Networks: